Cc1ccc(C)c(CN2C(=O)N(c3cc(Cl)ccc3C)S(=O)(=O)c3ccccc32)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?